• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• Twitter
• Newsletter

Advertisement

Product › Details

RNAi drug (RNAi therapeutic)

	Next higher product group	pharmaceutical_o

Record changed: 2021-07-05

Advertisement

More documents for RNAi drug (RNAi therapeutic)

• [1] Centogene N.V.. (12/8/20). "Press Release: Centogene and Alnylam Pharmaceuticals Launch a New Clinical Program Aimed at Revolutionizing the Diagnosis of Hereditary Transthyretin-Related Amyloidosis (“ATTRv”)". Cambridge, MA, Rostock, Berlin & Munich....
• [2] Evox Therapeutics Ltd.. (6/9/20). "Press Release: Evox Therapeutics Announces a Multi-target RNA Interference and Antisense Research Collaboration and License Agreement with Lilly"....
• [3] Silence Therapeutics plc. (3/25/20). "Press Release: Silence Therapeutics Announces R&D Update". London....
• [4] Freeline Therapeutics Ltd.. (2/4/20). "Press Release: Freeline Appoints Theresa Heggie as Chief Executive". London....
• [5] Novo Nordisk A/S. (11/18/19). "Press Release: Dicerna and Novo Nordisk Enter Agreement to Discover and Develop RNAi Therapies for Liver-related Cardio-metabolic Diseases". Lexington, MA & Bagsvaerd....
• [6] Silence Therapeutics plc. (8/5/19). "Press Release: Silence Therapeutics Appoints Jørgen Wittendorff as Head of Manufacturing". London....
• [7] Silence Therapeutics plc. (7/18/19). "Press Release: Silence Therapeutics and Mallinckrodt Announce Collaboration to Develop and Commercialize RNAi Therapeutics for Complement-mediated Diseases". London & Staines-upon-Thames....
• [8] Silence Therapeutics plc. (7/18/19). "Press Release: Mallinckrodt to Make an Equity Investment in Silence Therapeutics as Part of a Collaboration". London & Staines-upon-Thames....
• [9] Alnylam Pharmaceuticals, Inc.. (1/21/19). "Press Release: Alnylam Pharmaceuticals and Medison Pharma Partner to Commercialize RNAi Therapeutics in Israel". Zug & Petach Tikva....
• [10] Alnylam Pharmaceuticals, Inc.. (12/10/18). "Press Release: Alnylam Announces Settlement of Litigation with Silence Therapeutics". Cambridge, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.